We will offer a comprehensive program in the future
doi: 10.3389/fimmu.2013.00169 2 ChikumaS
1,3 A 2025 systematic review in the International Journal of Dermatology confirmed that among GLP-1 receptor agonists, semaglutide and tirzepatide showed the highest reported incidence of hair loss, with telogen effluvium and androgenetic alopecia (AGA) identified as the predominant subtypes
Regarding GLP-2, Gu and colleagues evaluated a modified GLP-2 analog in mice, demonstrating that it reduced disease severity by restoring epithelial junctions and barrier integrity (87), complementing their currently approved use of GLP-2 analogs in short bowel syndrome (88, 89)
Youll receive one-on-one medical oversight, work with a dedicated coach, and complete regular progress assessments throughout the year
doi: 10.1517/14656566.8.15.2593 47 BrayGM